Therefore, a change in MAVS expression (because of ADAR1 editing) within the tumor seems to be a strong corollary of ISG/NF-κB signaling and presumably of downstream interferon production and tumor survival signaling, respectively. The gene discussed is NFKB1; the disease is neoplasm.